Joinville-Le-Pont, France

Denis Furling

This inventor holds 1 USPTO granted patent. Top assignees: Association Institut De Myologie, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis Furling. Retrieved from https://idiyas.com/inventor/denis-furling-lefezsfr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Denis Furling: Innovator in Myotonic Dystrophy Treatment

Introduction

Denis Furling is a notable inventor based in Joinville-Le-Pont, France. He has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. His innovative work has led to the development of a patent that addresses this challenging condition.

Latest Patents

Denis Furling holds a patent for the "Treatment of Myotonic Dystrophy." This patent represents a crucial advancement in the management of this genetic disorder, which affects muscle function and can lead to various complications.

Career Highlights

Throughout his career, Denis has worked with esteemed organizations such as the Association Institut De Myologie and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Denis has collaborated with notable colleagues, including Nicolas Sergeant and Marie-Laure Caillet-Boudin. These partnerships have enriched his research and expanded the impact of his work in the medical community.

Conclusion

Denis Furling's contributions to the treatment of myotonic dystrophy highlight his dedication to medical innovation. His patent and collaborations reflect his commitment to improving the lives of those affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…